AcelRx Pharmaceuticals Inc. (ACRX)

2.20
NASDAQ : Health Technology
Prev Close 2.25
Day Low/High 2.16 / 2.27
52 Wk Low/High 1.99 / 5.05
Avg Volume 1.22M
Exchange NASDAQ
Shares Outstanding 79.44M
Market Cap 178.73M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

Our portfolio fell along with the broader market (especially small-caps), but there were some bright spots as well.

Earnings Buffet: Updates on 4 Portfolio Names

Here's our current thinking on AcelRx Pharmaceuticals, Antares Pharma, CPI Aerostructures and Pareteum.

Stocks Under $10 Weekly Summary

While the portfolio experienced some pain last week along with the broader market, 12 of our holdings beat the Russell 2000 either on an absolute or relative basis.

AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

51 REMS-certified facilities and 43 formulary approvals since launch

Stocks Under $10 Weekly Summary

We exited a position last week for a nice gain as the market continued to rise.

Interesting ACRX Put And Call Options For March 2020

Interesting ACRX Put And Call Options For March 2020

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading this week, for the March 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Stocks Under $10 Weekly Summary

As the momentum of earnings season rose last week, we made several trades including initiating a new position in Innovative Solutions and Support.

Stocks Under $10 Weekly Summary

We added to one position last week as as the small-cap heavy Russell 2000 dipped.

Stocks Under $10 Weekly Summary

We added to one position and initiated another during a shortened holiday week.

Stocks Under $10 Weekly Summary

We initiated a new position and added to a couple of others as we closed the books on the second quarter.

AcelRx Added To The Russell 2000® And 3000® Indexes

AcelRx Added To The Russell 2000® And 3000® Indexes

REDWOOD CITY, Calif., July 1, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

Stocks Under $10 Weekly Summary

Last week we started two new positions, trimmed a winner and exited another name as the markets moved higher across the board.

Stocks Under $10 Weekly Summary

With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.

Stocks Under $10 Weekly Summary

With the market rebounding, the majority of our positions rose week over week.

Stocks Under $10 Weekly Summary

During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.

AcelRx Announces The Closing Of A $25 Million Senior Secured Debt Facility

AcelRx Announces The Closing Of A $25 Million Senior Secured Debt Facility

REDWOOD CITY, Calif., June 3, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

Stocks Under $10 Weekly Summary

Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.

First Week Of July 19th Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week Of July 19th Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new July 19th contracts and identified the following put contract of particular interest.

Stocks Under $10 Weekly Summary

Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.

Stocks Under $10 Weekly Summary

We took some nice profits trimming a position, exited a name and added to another holding during a challenging week for stocks.

AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results

AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results

REDWOOD CITY, Calif., May 8, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

Stocks Under $10 Weekly Summary

We added to three positions and pulled the plug on another during a solid week for small-cap stocks.

Stocks Under $10 Weekly Summary

We ditched one position and added to another last week as small-cap stocks trended higher.

First Week Of December 20th Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week Of December 20th Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the December 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

AcelRx To Announce First Quarter 2019 Results And Provide An Update On The Company's Business On Wednesday, May 8th, 2019

AcelRx To Announce First Quarter 2019 Results And Provide An Update On The Company's Business On Wednesday, May 8th, 2019

REDWOOD CITY, Calif., April 25, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

Stocks Under $10 Weekly Summary

During the week, we took a starter position in Encana Corp. and boosted our cash position by trimming iShares Russell 2000 ETF.

Stocks Under $10 Weekly Summary

We made several trades last week as the overall market grinded modestly higher.

TheStreet Quant Rating: D- (Sell)